← Back to Search

Procedure

Stereotactic Liver Ablation for Liver Cancer

N/A

Recruiting

Led By Bruno Odisio, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients presenting with up to 5 colorectal liver metastasis measuring up to 5 cm who are referred to percutaneous ablation

Distance to central bile ducts > 1 cm

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial is investigating a new, high-precision liver ablation technique to treat primary and secondary liver cancers. The technique includes stereotactic-guidance, CT during hepatic arteriography-based imaging analysis, and computer-based software assessment of ablation margins.

Who is the study for?

The STEREOLAB trial is for adults over 18 with up to five liver tumors from colorectal cancer, each no larger than 5 cm. They must be able to undergo a precise ablation treatment and have a life expectancy of more than a year. Participants need good kidney function, no severe iodine allergies, and can't be too close to vital bile ducts or severely ill based on specific health scores.Check my eligibility

What is being tested?

This study tests a high-precision liver ablation technique using stereotactic guidance, CT imaging during hepatic arteriography, and software for assessing if the tumor's been fully treated. It aims to see how well this combined method works in treating primary and secondary liver cancers.See study design

What are the potential side effects?

While not explicitly listed in the provided information, typical side effects of liver ablation procedures may include pain at the site of treatment, bleeding internally or externally, infection risks at the probe insertion point, damage to nearby organs or structures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have up to 5 liver tumors from colorectal cancer, each no larger than 5 cm, and am referred for a specific tumor-removal procedure.

Select...

My bile duct condition is more than 1 cm away from the central bile ducts.

Select...

I am older than 18 years.

Select...

I can take care of myself and perform daily activities.

Select...

My kidneys work well and I'm not severely allergic to iodine-based dyes.

Select...

My tumor can be fully treated with a margin of safety.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Quality of Life Questionnaire (EQ-5D-3L)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Liver ablationExperimental Treatment1 Intervention

The ablation procedure will be performed in 1 day

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,984 Previous Clinical Trials

1,789,037 Total Patients Enrolled

Bruno Odisio, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Liver ablation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05361551 — N/A

Liver Ablation Research Study Groups: Liver ablation

Liver Ablation Clinical Trial 2023: Liver ablation Highlights & Side Effects. Trial Name: NCT05361551 — N/A

Liver ablation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05361551 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollment opportunities for this research study?

"Confirmed. According to the clinicaltrials.gov website, this trial has ceased recruiting participants after it was posted on October 31st 2022 and last updated on May 4th 2022. Nevertheless, there are 1 other trials which are actively taking in patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)

2023. "Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05361551.